Posted in | News | Nanomedicine

Arrowhead to Discuss its Nanomedicine Portfolio at Bio Investor Forum

Arrowhead Research Corporation (NASDAQ:ARWR) today announced that Dr. Christopher Anzalone, Chief Executive Officer, will be presenting at the 9th Annual BIO Investor Forum at 4:30 p.m. PT on Tuesday, October 5, 2010, at the Palace Hotel in San Francisco, CA.

Dr. Anzalone will be discussing the Company and its increased focus on its nanomedicine portfolio, including clinical results.

The BIO Investor Forum is a national investor conference featuring private and emerging public companies. The meeting attracts healthcare venture capital and public market investors and research analysts. In addition, the BIO Investor Forum draws business development executives from global pharmaceutical and biotechnology companies.

Source: http://www.arrowheadresearch.com/

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Arrowhead Pharmaceutical. (2019, February 13). Arrowhead to Discuss its Nanomedicine Portfolio at Bio Investor Forum. AZoNano. Retrieved on December 06, 2022 from https://www.azonano.com/news.aspx?newsID=19751.

  • MLA

    Arrowhead Pharmaceutical. "Arrowhead to Discuss its Nanomedicine Portfolio at Bio Investor Forum". AZoNano. 06 December 2022. <https://www.azonano.com/news.aspx?newsID=19751>.

  • Chicago

    Arrowhead Pharmaceutical. "Arrowhead to Discuss its Nanomedicine Portfolio at Bio Investor Forum". AZoNano. https://www.azonano.com/news.aspx?newsID=19751. (accessed December 06, 2022).

  • Harvard

    Arrowhead Pharmaceutical. 2019. Arrowhead to Discuss its Nanomedicine Portfolio at Bio Investor Forum. AZoNano, viewed 06 December 2022, https://www.azonano.com/news.aspx?newsID=19751.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit